Impact of hormone replacement therapy on postprandial lipoproteins and lipoprotein(a) in normolipidemic postmenopausal women
- 1 July 1994
- journal article
- clinical trial
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 72 (7) , 502-507
- https://doi.org/10.1007/bf00207478
Abstract
In 43 normolipidemic postmenopausal women we studied fasting and postprandial (oral fat load with 50 g fat per square meter; blood sampling for 5 h) lipoprotein components and lipoprotein(a) levels before and with the administration of conjugated equine estrogens opposed by medrogestone (on days 11–21). Data was compared intraindividually; the second testing was performed during the last 5 days of the combined estrogen/progestogen phase of the third cycle. Fasting low-density lipoprotein (LDL) and total cholesterol concentrations decreased significantly; high-density lipoprotein (HDL) cholesterol, including subfractions HDL2 and HDL3, was not changed. Fasting triglyceride concentrations increased. All lipoprotein fractions measured showed a postprandial elevation with the exception of chylomicron cholesterol concentrations. There was a significant effect of hormone replacement therapy on the postprandial course of total cholesterol (decrease; P < 0.001), VLDL cholesterol (increase; P = 0.025), and the triglyceride proportion in the LDL plus HDL fraction (increase; P < 0.001). With hormone replacement therapy the postprandial curve of total triglycerides was increased only 1 h after the fat load while chylomicron triglyceride concentrations were lowered after 5 h. VLDL triglycerides were not influenced. In all patients with lipoprotein(a) levels above 10 mg/dl, this parameter decreased (about 25%). Although increasing fasting triglyceride concentrations, hormone replacement therapy does not bring about an exaggerated postprandial increase in triglycerides. Postprandial chylomicron clearance is evidently promoted. Hormone replacement therapy leads to a small increase in triglycerides in the LDL plus HDL fraction by inhibiting hepatic lipase activity. Moreover, the decrease in lipoprotein(a) levels may contribute to the antiatherosclerotic effect.Keywords
This publication has 24 references indexed in Scilit:
- Influence of age and menopause on serum lipids and lipoproteins in healthy womenAtherosclerosis, 1993
- HDLs and alimentary lipemia. Studies in men with previous myocardial infarction at a young age.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Postprandiale Lipämie und Arteriosklerose*Deutsche Medizinische Wochenschrift (1946), 1992
- Sex hormones, lipoproteins, and cardiovascular riskAtherosclerosis, 1991
- Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal womenThe Lancet, 1991
- Hormonal determinants of apolipoprotein B,E receptor expression in human liver. Positive association of receptor expression with plasma estrone concentration in middle-aged/elderly womenBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism.Journal of Clinical Investigation, 1988
- Evaluation of a new HDL2/HDL3 quantitation method based on precipitation with polyethylene glycolClinica Chimica Acta; International Journal of Clinical Chemistry, 1985